Efficacy and safety of recombinant human erythropoietin to prevent the anaemias of prematurity. European Randomized Multicenter Trial.
Obladen
M
M
University Children's Hospital, Free University, Department of Neonatology, Berlin, FRG.
Maier
R
R
Segerer
H
H
Grauel
E L
EL
Holland
B M
BM
Stewart
G
G
Jorch
G
G
Rabe
H
H
Linderkamp
O
O
Hoffmann
H G
HG
D000740:Anemia / Q000517:prevention & control*; D004920:Erythropoiesis / Q000187:drug effects; D004921:Erythropoietin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000517:prevention & control*; D008297:Male; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
D011994:Recombinant Proteins; D004921:Erythropoietin